Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

520
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
520
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

125
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
125

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial intelligence and medical futility.

BMC medical informatics and decision making·2026
Same author

Unique Digital Images as Incentives in Clinical Trials: A Digital Shift Toward Meaningful Participation.

Journal of medical Internet research·2026
Same author

Guiding Policymakers Toward Better AI Ethics Integration in Healthcare Regulation-Lessons from Singapore.

Journal of clinical medicine·2026
Same author

The Promise and Peril of Precision Medicine : How Asian Perspectives on Naturalness Can Help to Reframe Disability Narratives.

Journal of bioethical inquiry·2026
Same author

<i>Ziran</i> (): the Daoist concept of naturalness, non-intervention and gentle medicine.

Journal of medical ethics·2026
Same author

Reclaiming 'abnormal' embryos after preimplantation genetic testing for aneuploidy: patients' perspectives on transferring embryos against prior institutional advice.

Human reproduction open·2026
Same journal

Between Safeguard and Constraint: Navigating Patient Autonomy in Protective Laws for Medical Assistance in Dying.

Bioethics·2026
Same journal

Bioethics of Space Exploration: Life, Risk, and Responsibility Beyond Earth.

Bioethics·2026
Same journal

The Concept of Harm in Medical Ethics.

Bioethics·2026
Same journal

On the Destruction and Humanitarianisation of the Health System in Gaza and the Need for a Biopolitical Bioethics.

Bioethics·2026
Same journal

Shaping Future Children, Sex Selection, and "Normal" Human Capacities.

Bioethics·2026
Same journal

Health Research Funders and Justice: Obligations to Coordinate and Counterbalance.

Bioethics·2026
See all related articles

Related Experiment Video

Updated: Mar 25, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.3K

Assessing Risk Thresholds in Controlled Human Infection Models (CHIM).

Alexa Nord-Bronzyk1, Barnaby Young2, Jerry Menikoff1

  • 1Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singpaore, Singapore.

Bioethics
|March 24, 2026
PubMed
Summary
This summary is machine-generated.

Controlled Human Infection Models (CHIMs) offer benefits for vaccine and therapeutic development but raise ethical concerns. This study proposes three frameworks for evaluating risk thresholds in CHIMs to guide future research.

Keywords:
challenge trialsresearch ethicsrisk thresholdsrisk‐benefit assessments

More Related Videos

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
12:04

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

Published on: May 9, 2018

14.9K
Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment
09:27

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment

Published on: May 6, 2020

12.1K

Related Experiment Videos

Last Updated: Mar 25, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.3K
Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
12:04

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

Published on: May 9, 2018

14.9K
Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment
09:27

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment

Published on: May 6, 2020

12.1K

Area of Science:

  • Medical Ethics
  • Infectious Disease Research
  • Clinical Trial Design

Background:

  • Controlled Human Infection Models (CHIMs) accelerate vaccine and therapeutic development by deliberately exposing volunteers to pathogens.
  • CHIMs present unique ethical challenges, particularly regarding acceptable risk levels for participants, especially in high-risk scenarios.
  • Existing ethical guidelines for CHIMs are well-established for low-risk pathogens but require re-evaluation for emerging threats and pandemic preparedness.

Purpose of the Study:

  • To address the ethical considerations surrounding risk thresholds in Controlled Human Infection Models (CHIMs).
  • To propose a taxonomy of approaches for evaluating and setting ethical risk limits in CHIMs.
  • To provide a resource for researchers navigating the ethical permissibility of current and future CHIM studies.

Main Methods:

  • The study reviews the ethical landscape of CHIMs, contrasting them with other early-phase clinical trials.
  • It analyzes the unique ethical considerations posed by CHIMs, particularly concerning participant risk.
  • A proposed taxonomy outlines three distinct approaches to determining risk thresholds: consistency, community engagement, and no risk threshold.

Main Results:

  • The paper identifies a critical need for frameworks to ethically evaluate higher-risk CHIMs, especially in the context of future pandemic preparedness.
  • Three distinct approaches—consistency, engaging community perspectives, and no risk threshold—are presented as potential models for setting ethical risk boundaries.
  • The strengths and weaknesses of each proposed approach are explored to inform ethical decision-making.

Conclusions:

  • Establishing clear ethical guidelines and risk thresholds for CHIMs is crucial for advancing medical research while protecting participants.
  • The proposed taxonomy offers a structured method for the research community to deliberate on the ethical permissibility of CHIMs with varying risk levels.
  • Future CHIM research, particularly for pandemic response, necessitates careful consideration of participant safety and societal values when defining acceptable risks.